Medline $MDLN Stock Purchased by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. grew its stake in shares of Medline (NASDAQ:MDLN) by 330.3% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 100,000 shares of the company’s stock after buying an additional 76,761 shares during the period. Jefferies Financial Group Inc.’s holdings in Medline were worth $3,470,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in MDLN. Andra AP fonden purchased a new stake in Medline during the second quarter valued at about $3,180,000. Cetera Investment Advisers boosted its holdings in shares of Medline by 128.4% during the first quarter. Cetera Investment Advisers now owns 52,088 shares of the company’s stock worth $2,318,000 after purchasing an additional 29,282 shares during the period. Baird Financial Group Inc. grew its stake in shares of Medline by 1,151.5% in the second quarter. Baird Financial Group Inc. now owns 379,944 shares of the company’s stock worth $14,985,000 after purchasing an additional 349,584 shares during the last quarter. WINTON GROUP Ltd grew its stake in shares of Medline by 1,263.0% in the second quarter. WINTON GROUP Ltd now owns 367,057 shares of the company’s stock worth $14,477,000 after purchasing an additional 340,127 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. purchased a new position in Medline during the 1st quarter valued at about $1,177,000.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Wall Street Zen raised Medline from a “hold” rating to a “buy” rating in a research report on Saturday, November 7th. Weiss Ratings raised Medline from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday. William Blair reissued an “outperform” rating on shares of Medline in a research note on Wednesday, September 23rd. BMO Capital Markets reaffirmed an “outperform” rating and issued a $47.00 price target on shares of Medline in a research note on Thursday, August 6th. Finally, Deutsche Bank set a $37.00 price target on shares of Medline and gave the company a “hold” rating in a report on Thursday, August 6th. Twenty-three research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Medline currently has a consensus rating of “Moderate Buy” and a consensus target price of $46.08.

Medline Stock Performance

Shares of MDLN opened at $39.98 on Friday. The company has a quick ratio of 2.51, a current ratio of 4.04 and a debt-to-equity ratio of 0.65. The stock has a market cap of $52.56 billion and a P/E ratio of 34.84. The business’s 50 day moving average price is $35.22 and its 200-day moving average price is $39.40. Medline has a 52 week low of $31.37 and a 52 week high of $50.88.

Medline (NASDAQ:MDLN) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.12. The firm had revenue of $7.86 billion during the quarter. Medline had a return on equity of 8.21% and a net margin of 1.84%. Equities research analysts anticipate that Medline will post 1.58 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Medline news, major shareholder Private Ltd Gic sold 2,088,987 shares of Medline stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $35.05, for a total value of $73,218,994.35. Following the completion of the transaction, the insider directly owned 16,453,806 shares of the company’s stock, valued at approximately $576,705,900.30. The trade was a 11.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In the last three months, insiders have sold 6,348,676 shares of company stock worth $224,525,137. 0.81% of the stock is currently owned by company insiders.

Medline Profile

Medline is a healthcare products manufacturer and distributor serving providers across the care continuum. Its customers include hospitals, surgery centers, physician practices, long-term care facilities and home-care organizations. The company offers a broad range of medical and surgical supplies, including products for infection prevention, wound care and patient care, as well as apparel and equipment. Medline also provides supply-chain and logistics services to healthcare organizations. Founded in 1966, Medline is headquartered in Northfield, Illinois, and serves customers in the United States and internationally.